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Neurobiology of Disease
Setdb1 Histone Methyltransferase Regulates Mood-Related
Behaviors and Expression of the NMDA Receptor Subunit
NR2B
Yan Jiang,1,2Mira Jakovcevski,1 Rahul Bharadwaj,1,2 Caroline Connor,1,2 Frederick A. Schroeder,1 Cong L. Lin,1
Juerg Straubhaar,3 Gilles Martin,1 and Schahram Akbarian1
1Department of Psychiatry, Brudnick Neuropsychiatric Research Institute, 2Graduate School of Biomedical Sciences, and 3Program in Molecular Medicine,
University of Massachusetts Medical School, Worcester, Massachusetts 01604
Histone methyltransferases specific for the histone H3-lysine 9 residue, including Setdb1 (Set domain, bifurcated 1)/Eset/Kmt1e are
associated with repressive chromatin remodeling and expressed in adult brain, but potential effects on neuronal function and behavior
remain unexplored. Here, we report that transgenic mice with increased Setdb1 expression in adult forebrain neurons show
antidepressant-like phenotypes in behavioral paradigms for anhedonia, despair, and learned helplessness. Chromatin immunoprecipi-
tation in conjunction with DNA tiling arrays (ChIP-chip) revealed that genomic occupancies of neuronal Setdb1 are limited to1% of
annotated genes, which include the NMDA receptor subunit NR2B/Grin2B and other ionotropic glutamate receptor genes. Chromatin
conformation capture and Setdb1-ChIP revealed a loop formation tethering the NR2B/Grin2b promoter to the Setdb1 target site posi-
tioned30kbdownstreamof the transcription start site. Inhippocampusandventral striatum, twokey structures in theneuronal circuitry
regulating mood-related behaviors, Setdb1-mediated repressive histone methylation at NR2B/Grin2b was associated with decreased
NR2B expression and EPSP insensitivity to pharmacological blockade of NR2B, and accelerated NMDA receptor desensitization consis-
tent with a shift in NR2A/B subunit ratios. In wild-type mice, systemic treatment with the NR2B antagonist, Ro25-6981 [R-(R,S)--(4-
hydroxyphenyl)--methyl-4-(phenylmethyl)-1-piperidine propranol], and hippocampal small interfering RNA-mediatedNR2B/Grin2b
knockdown resulted in behavioral changes similar to those elicited by the Setdb1 transgene. Together, these findings point to a role for
neuronal Setdb1 in the regulation of affective and motivational behaviors through repressive chromatin remodeling at a select set of
target genes, resulting in altered NMDA receptor subunit composition and other molecular adaptations.
Introduction
Posttranslational histone modifications are involved in epige-
netic regulation of gene expression and genome organization
(Berger, 2007; Roth and Sweatt, 2009). Numerous studies high-
lighted the role of histone acetylation involved in various types of
neuronal plasticity (Huang et al., 2002; Shahbazian et al., 2002;
Brami-Cherrier et al., 2005; Thatcher and LaSalle, 2006; Weaver
et al., 2006; Fischer et al., 2007; Lubin and Sweatt, 2007; Oliveira
et al., 2007; Vecsey et al., 2007; Borrelli et al., 2008; Jiang et al.,
2008a; Pandey et al., 2008; Crepaldi and Riccio, 2009; Guidotti et
al., 2009). Furthermore, alterations in levels and activity of his-
tone deacetylase enzymes profoundly affect depression-related
behaviors in some preclinical models, which could point to novel
targets for antidepressant drug development (Tsankova et al.,
2006; Duman and Newton, 2007; Schroeder et al., 2007; Covington
et al., 2009; Grayson et al., 2009; Gundersen and Blendy, 2009;
Hobara et al., 2009). However, much less is known about the role
of chromatin modifiers regulating histone modifications other
than acetylation in the brain, includingmethylation (Gupta et al.,
2010). Of note, various chromatin remodeling complexes associ-
ated with transcriptional repression involve histonemethyltrans-
ferases (HMTs) for histone H3-lysine 9 (H3K9) and other lysine
residues (Cedar and Bergman, 2009). A subset of H3K9 HMTs,
including G9a and GLP/Eu-HMTAse1, assembled as heteromers
(Tachibana et al., 2008), play a role for large scale chromatin
organization during lineage restriction and cellular differenti-
ation (Wen et al., 2009) and are essential for orderly brain devel-
opment (Kleefstra et al., 2006). Additional members of the H3K9
HMT family, including Setdb1 (Set domain, bifurcated 1, also
known as Eset/Kg1t/Kmt1e) and Suv39h1, show widespread
expression in developing and adult brains (Lein et al., 2007).
Although regulation of Suv39h1 expression in the nucleus ac-
cumbens (a core component in the brain’s reward circuitry) is
involved in stimulant addiction (Renthal et al., 2008), the role of
Setdb1 for neuronal gene expression and behavior remains
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largely unexplored. Furthermore, although single genes, includ-
ing p53BP2 and RASSF1A, were well described as Setdb1 targets
in cancer cell lines (Li et al., 2006), the binding profile of Setdb1
on a genome-wide scale remains unexplored in the brain. To this
end, we generated transgenic mouse lines with increased Setdb1
expression and activity, complemented by Setdb1 gene delivery
studies in human cell lines derived from neural tissue. We use
multiple lines of evidence to show that Setdb1 elicits changes in
affective and motivational behaviors through a mechanism that
involves partial repression of theNMDA receptor subunit NR2B/
Grin2b. Notably,GRIN2B is strongly associated with genetic risk
for bipolar affective disorder and schizophrenia in selected pop-
ulations (Fallin et al., 2005; Avramopoulos et al., 2007; Allen et
al., 2008), and furthermore, the nonselective NMDA antagonist
ketamine and the NR2B-selective antagonist (1S, 2S)-1-(4-
hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol
(CP-101,606) were recently identified as fast-acting antidepres-
sants in subjects with treatment-resistant depression (Berman et
al., 2000; Zarate et al., 2006; Preskorn et al., 2008). Therefore, the
findings presented here identify epigenetic fine-tuning of NMDA
receptor gene expression as a new layer of regulation for the
brain’s affective and motivational states.
Materials andMethods
Animals
All experimental procedures were approved by the Institutional Animal
Care and Use Committee of the University of Massachusetts Medical
School. Animals were housed in groups of two to four per cage with food
and water ad libitum under a 12 h light/dark cycle with lights on 7 A.M.
Generation of CaMKII-Setdb1 (CK-Setdb1) transgenic mice
Amyc-tagged 4.6 kbmouse ESET/Setdb1 full-length cDNA fused to sim-
ian virus (SV40) late polyadenylation signal (SV40 pA) was isolated from
plasmid pCS2-MT-ESET (a gift fromDr. Liu Yang, University of Arkan-
sas for Medical Sciences, Little Rock, AR) (Yang et al., 2003) and ligated
to the 8 kb CaMKII  promoter (Choi et al., 1991; Mayford et al., 1996)
after insertion of a Kozak sequence, 5-AGCCACCATGG-3, to replace
5-TTAAAGCTATGG-3 in pCS2-MT-ESET. Linearized vector was in-
jected into C57BL/6  SJL F2 hybrid mouse embryos; two out of four
different founder lines showedwidespread expression of the transgene in
forebrain. These two colonies were kept in different housing rooms. For
each experiment,CK-Setdb1/0mice were compared to gender-matched
littermate controls housed in the same cage.
Immunohistochemistry
Coronal sections (18 m thick) from perfusion-fixed (by phosphate-
buffered 4% paraformaldehyde) adult brain were processed free-floating
for anti-myc (A-14) (Santa Cruz Biotechnology; catalog #sc-789) immu-
noreactivity, which was detected with diaminobenzidine using an ABC
kit (Vector Laboratories). This antibody recognizes epitopes of human
c-myc, but cross-reactivity with the murine homolog was not detectable.
For anti-myc immunofluorescence, fresh frozen brain sections were
fixed with 100% methanol at 20°C for 10 min. Nuclei isolated from
brain tissue homogenates in hypotonic solution were fixed, spread on
slides, and air dried, and then stained for anti-myc and anti-NeuN (Mil-
lipore Bioscience Research Reagents; MAB377).
Immunoblotting
Samples were homogenized directly in 1 Laemmli buffer with 1
Complete Proteinase Inhibitor (Roche Applied Science; catalog
#11697498001), incubated at 37°C for 10 min, and centrifuged at
13,500 g at 4°C for 5 min. The supernatant was denatured at 95°C for
5min electrophoresed on a 4–20% linear gradient Tris-HCl gel, and then
transferred to nitrocellulose membrane. Immunostainings were per-
formed with anti-myc (Santa Cruz Biotechnology; catalog #sc-789), two
anti-Setdb1s (Ab-1, Millipore, catalog #07-378; Ab-2, Santa Cruz Bio-
technology, catalog #sc-66884), anti-Grin2b (Millipore Bioscience Re-
search Reagents; catalog #AB1557p), anti-Grin2a (Millipore Bioscience
Research Reagents; catalog #AB1555p), and for loading controls, anti-
glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Abcam; catalog
#ab9485) and anti-modification-independent histone H3 (Millipore;
catalog #07-690). Immunoreactivity was detected with peroxidase-
conjugated secondary antibody in conjunction with chemiluminesence-
based film autoradiography. For quantification, Quantity-One (Bio-Rad)
software was used.
Real-time reverse transcriptase PCR
Total RNAwas extracted fromcerebral cortex, striatum, or hippocampus
using the RNeasy Lipid Tissue Mini kit (Qiagen; catalog #74804) and
then subjected to SYBR green based one-step reverse transcriptase (RT)-
PCR using Taqman One-Step RT-PCR Mix Reagents (Roche; catalog
#4309169). Primers are listed in supplemental Table 1 (available at www.
jneurosci.org as supplemental material). Ribosomal RNA (18S) was used
as an internal control (Schroeder et al., 2007). Quantification was as
described previously (Huang et al., 2006).
Chromatin immunoprecipitation
Samples were fixed in 1% formalin for 5 min at room temperature,
sonicated at power level 6 (Branson Sonifier 250) on icewater (six runs of
1 min pulsing with 1 min resting interval), precleaned, and then sub-
jected to anti-trimethyl H3K9 (H3K9me3; Millipore; catalog #07-442),
anti-H3K9me2 (Millipore; catalog #07-441), anti-myc (Santa Cruz Bio-
technology, catalog #sc-789), anti-Setdb1 (Santa Cruz Biotechnology;
catalogs #c-66884), or anti-Krueppel-associated box domain (KRAB)-
associated protein 1 (KAP-1; Abcam; catalog #ab22553) immunopre-
cipitation. Control samples were processed with normal rabbit IgG
(Millipore; catalog #12-370) in parallel to samples with specific antibod-
ies. For H3K9me3 chromatin immunoprecipitation (ChIP), input DNA
and immunoprecipitated DNAwere subjected to slot-blot hybridization
using a 32P-labeled oligonucleotide probe, 5GGACCTGGAATATGGC
GAGAA A 3, targeting mouse major satellite DNA. For PCR-based
quantifications of ChIP assays, input DNA and immunoprecipitated
DNA were subjected to SYBR-green-based real-time PCR using ChIP
primers listed in supplemental Table 1 (available at www.jneurosci.org as
supplemental material).
Chromatin immunoprecipitation followed by massively
parallel sequencing
For two wild-type adult forebrains (mouse), anti-histone H3 trimethyl-
lysine 4 (H3K4me3) ChIP was performed on micrococcal nuclease-
prepared digests of nuclei as described previously (Huang et al., 2007).
Subsequently, immunoprecipitated DNA was processed for deep se-
quencing by ligating the Genomic Adaptor OligoMix (Illumina) to frag-
ments. After PCR amplification, ligated fragments around 250 bp were
gel purified, and H3K4me3 ChIP libraries were deep sequenced by an
Illumina Genome Analyzer (GA II). Genomic regions containing a sig-
nificantly large number of reads, called peaks, were detected with MACS
software (Zhang et al., 2008). Mappable tags were uploaded to the Uni-
versity of California Santa Cruz (UCSC) genome browser and peaks at
the murine Grin2b locus (chromosome 6, 64.5 centimorgans) were
extracted.
Chromosome conformation capture
To map chromosomal loop formations within the proximal 40 kb of the
mouse Grin2b promoter, chromosome conformation capture (3C) was
performed as described previously, withminormodifications (Miele and
Dekker, 2009). In brief, forebrains of adult wild-type mice were homog-
enized in douncing buffer (Jiang et al., 2008b) with 2% formaldehyde to
cross-link higher-order chromatin in its current conformation. Nuclei
were extracted by ultracentrifugation under a sucrose gradient (Jiang et
al., 2008b), and then 250 l of 1NEB2 (New England Biolabs) restric-
tion enzymebufferwas added to the nuclei pellet. After resuspension, five
50l aliquots were prepared, and to each aliquot, 312l of 1NEB2 and
38 l of 1% SDS were added, and samples incubated at 65°C for 10 min
to separate non-cross-linked proteins from chromatin. Then, 44 l of
10% Triton X-100 was added to quench the SDS, gently mixed by pipet-
ting, and then digested with 400 units ofHindIII (New England Biolabs)
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at 37°C overnight under gentle horizontal shaking. Next, 86 l of 10%
SDS was added, and samples were incubated at 65°C for 30 min to inac-
tivate HindIII restriction enzyme. Then, each sample was added to 7.61
ml of ligation mixture. The mixture consisted of 745 l of 10% Triton
X-100, 745 l of 10 ligation buffer (1 M Tris HCl, pH 7.5, 1 MMgCl2, 1 M
DTT), 80 l of 10 mg/ml bovine serum albumin, 80 l of 100 mM ATP,
and 5960 l of H2O. To each sample, 50 l of T4 DNA ligase (1 U/l)
(Invitrogen) was added and incubated at 16°C for 4 h followed by reverse
cross-linking at 65°C overnight with simultaneous proteinase K diges-
tion (50l of 10mg/ml) to remove chromatin-associated proteins. Then,
for additional digestion, another 50 l of proteinase K was added and
incubated at 65°C for two additional hours. The ligated DNA fragments
from pooled aliquots were purified by standard phenol/chloroform ex-
traction and ethanol precipitation. To map for potential chromosomal
interactions in cis around 40 kb ofGrin2b, PCRwas conducted with both
“forward” and “reverse” primers positioned 5 to 3 on the sense strand
(see Fig. 4B, supplemental Table 1, available at www.jneurosci.org as
supplemental material). Each primer was positioned 200 bp or less
from the 3 end of each HindIII restriction site, thereby representing a
specificHindIII restriction fragment. PCR products were resolved in 2%
Invitrogen ultrapure gels. In total, three series of 3C interaction maps
were constructed by using a different restriction fragment anchor
(primer) for each series (see Fig. 4B). Two anchors were positioned
around theGrin2b transcription start site (TSS), and the third anchorwas
2 kb from the Setdb1 target sequence, separated by oneHindIII restric-
tion site. As a negative control, 3C libraries were generated from fore-
brain nuclei as described above, but without adding T4 ligase.
3C quantification
The level of interaction between any two regions along the genome is
proportional to the extent of ligation between the two regions. This is
measured semiquantitatively by the intensity of the PCR product gener-
ated using a specific primer pair representing the restriction fragments
from the interacting regions. To correct for variations in specific primer
pair efficiencies, each 3C-PCR product was normalized to the corre-
sponding PCRproduct from aHindIII digested and then ligated bacterial
artificial chromosome (BAC) representing 150 kb of genomic se-
quence surrounding the Grin2b TSS (BACPAC Resources Center). For
3C assays, the BAC template serves as a positive control and is expected to
represent all possible fragment interactions in equal amounts, thereby
controlling for primer efficiencies (Dekker, 2006;Miele et al., 2006;Miele
and Dekker, 2009).
Mouse tiling array
Amouse tiling array, GeneChip Mouse Tiling Array 2.0R F (Affymetrix;
catalog #900899), which is comprises6.5 million 25 mer oligonucleo-
tide probes covering chromosomes 6, 8, and 16, was used. After anti-myc
ChIP, soluble DNA was amplified with a whole genome amplification
system (Sigma; WGA2) according to a protocol from the Farnham Lab
(http://www.epigenome-noe.net/researchtools/protocol.php?protid30)
with slight modifications. After library preparation, DNA samples were
amplified by 14 cycles of unbiased PCR with universal primers, with 0.4
mM dUTP (Sigma; D0184). Amplified dUTP-incorporated DNA was
then fragmented into around 69 bp by uracil DNA glycosylase digestion
and end-labeled with biotin using the GeneChip WT Double Stranded
DNA Terminal Labeling Kit (Affymetrix; catalog #900812). Approxi-
mately 7.5 g of biotin-labeled DNA was hybridized to each tiling array.
Hybridization, washing, staining, and scanning were conducted
according to Affymetrix chromatin immunoprecipitation protocol
(Protocol P/N 7002238, www.affymetrix.com/support).
Significant signals were calculated using the model-based analysis of
tiling-arrays (MAT) algorithm as described previously (Johnson et al.,
2006). Genomic windows of 600 bp were scored (MATscore), and p
values were calculated based on the estimates of the nonenriched null
distribution of the MAT scores. A false discovery rate for a region was
calculated as the number of positive regions (above MATscore thresh-
old) divided by the number of negative regions (belowMATscore thresh-
old). Genomic sites and genes with significantly higher signals in CK-
Setdb1 than in wild-type samples are listed in Table 1 and supplemental
Table S2 (available at www.jneurosci.org as supplemental material).
Setdb1 expression in U87-MG cells
mycSetdb1 full-length cDNA was cloned into an AAV vector backbone
by ClaI and XbaI sites, and then transfected into the U87-MG human
glioma cell line by using Lipofectamine 2000 (Invitrogen; catalog
#11668) according to the manufacturer’s protocols. In brief, Opti-MEM
I Reduced SerumMedium was applied to cells with 80–90% confluence
(0.2–0.25 106 cells per well of a six-well plate, 2 106 cells per 10 cm
plate) 1 d before transfection. Four micrograms (six-well plate) or 24 g
(10 cm plate) of plasmid DNA was transfected. Cells that received Lipo-
fectamine only were processed in parallel as negative controls. Medium
was changed 4 h after transfection, and cells were kept in culture for
another 20 h. Cells were then harvested and prepared for anti-myc
XChIP, anti-Setdb1, and anti-Grin2b immunoblotting.
Electrophysiology: whole-cell recordings in hippocampal neurons
Hippocampus slices from age-matched postnatal day 18 (P18)–P21
CK-Setdb1/0/CK-H2BeGFP/0 and wild-type (CK-Setdb10/0/CK-
H2BeGFP/0) mice were prepared as reported previously (Martin and
Siggins, 2002). In brief, animals were anesthetized and decapitated,
and the brains rapidly transferred into an ice-cold (3–4°C) oxygen-
ated, low-calcium HEPES-buffered salt solution containing the fol-
lowing (in mM): 234 sucrose, 2.5 KCl, 2 NaH2PO4, 11 glucose, 4
MgSO4, 2 CaCl2, and 1.5 HEPES. A tissue block containing the hip-
pocampus was glued to a Teflon chuck and cut transversally with a
vibroslicer (Vibratome 1500). The slices (350 m thick) were incu-
bated for up to 6 h at room temperature (20–22°C) in a gassed (95%
O2 and 5% CO2) NaHCO3-buffered saline solution containing the
following (in mM): 116.4 NaCl, 1.8 CaCl2, 0.4 MgSO4, 5.36 KCl, 0.89
NaH2PO4, 5.5 glucose, 24 NaHCO3, 100 glutathione, 1 nitro-arginine,
Table 1. Gene hits from anti-myc ChIP-chip
Gene symbol
Setdb1 occupancy
Gene namea b
Angpt2 10.9 Int 1 Angiopoietin 2
Ano2 96.1 Int 6 Anoctamin 2
Cadm2 462.4 Int 1 Cell adhesion molecule 2
Cblb 162.6 Ex 17 E3ubiquitin-proteinligaseCasitasB-lineagelymphomaB
Clec1a 11.1 Int 1 C-type lectin domain, family 1, member A
Cntn4 563.3 Int 5 Contactin-4
Cntn4 703.4 Int 6 Contactin-4
Csmd1 1610.4 Int 52 CUB and sushi domain-containing protein 1 precursor
Eps8 27.0 Int 1 Epidermal growth factor receptor pathway substrate 8
Gm156 5.6 5 Gene model 156
Gpm6a 97.7 Int 4 Neuronal membrane glycoprotein M6-a
Grid2 40.9 Int 1 Grid2 glutamate receptor, ionotropic, delta 2
Grin2a 289.3 Int 5 Glutamate receptor, ionotropic, NMDA2A
Grin2b 31.4 Int 3 Glutamate receptor, ionotropic, NMDA2B
Il15 13.4 Int 1 Interleukin-15
Kcnd2 143.3 Int 1 Potassium voltage-gated channel, Shal-related
family, member 2
Klra1 1.4 5 Killer cell lectin-like receptor, subfamily A, member 1
Klra14 11.4 5 Killer cell lectin-like receptor, subfamily A, member 14
Klra9 85.7 Int 6 Killer cell lectin-like receptor, subfamily A, member 9
Klrk1 2.4 Int 1 Killer cell lectin-like receptor, subfamily K, member 1
Lmo3 204.8 Int 4 Lin11, Isl-1, Mec-3 domain only 3
Mcph1 134.9 Int 12 Microcephalin
Mtmr7 1.9 Int 1 Myotubularin-related protein 7
Olfr203 1.6 5 Olfactory receptor 203
Pik3c2g 232.4 Int 18 Phosphatidylinositol 3-kinase, C2 domain containing,
 polypeptide
Ptprz1 154.4 Int 17 Protein tyrosine phosphatase, receptor type Z,
polypeptide 1
Robo2 239.9 Int 2 Roundabout homolog 2 precursor
Styk1 6.0 Int 3 Serine/threonine/tyrosine kinase 1
Tmem39a 1.5 5 Transmembrane protein 39A
Int, Intron; Ex, exon; 5, 5 upstream of TSS. All p values are0.00001; n 3 CK-Setdb1 and, as negative control,
3 wild-type littermates.
a The length from gene hits to TSS (5 to 3; in kilobases).
b The length range of gene hits is from 624 to 1000 bp.
7154 • J. Neurosci., May 26, 2010 • 30(21):7152–7167 Jiang et al. • Setdb1 Methyltransferase and Affective Behaviors
and 1 kynurenic acid; pH was adjusted to 7.35 with NaOH, 300–305
mOsm/L. After 1 h of incubation, the region of the hippocampus was
dissected out with the aid of a dissecting microscope, and the tissue was
incubated for 15 min in an oxygenated (100%O2 with constant stirring)
HEPES-buffered solution in the inner chamber of a Cell-Stirr flask
(Wheaton) containing protease XIV (1 mg/ml) and the following (in
mM): 136 NaCl, 0.44 KH2PO4, 2.2 KCl, 0.35 NaH2PO4, 5.5 glucose, 10
HEPES, 100 glutathione, 1 nitro-arginine, 1 kynurenic acid, and 1 pyru-
vic acid, pH 7.35 with NaOH, 300–305 mOsm. The temperature of this
solutionwas kept constant (36°C) by a circulating water bath in the outer
chamber of the flask.
After enzymatic digestion, the tissue was transferred into a centrifuge
tube and rinsed twice with an Na-isethionate solution. The tube was
then filled with 5 ml of Na-isethionate solution and after 10 min, the
tissue was triturated using fire-polished Pasteur pipettes with succes-
sively smaller tip diameters. The supernatant was plated onto a 35 mm
Petri dish placed on the stage of the inverted fluorescence microscope.
The cells were allowed to attach to the bottom of the dish for at least 10
min before replacing the Na-isethionate solution with normal Locke’s
solution composed of the following (inmM): 142NaCl, 2KCl, 1CaCl2, 23
glucose, 15 HEPES, pH 7.35 with NaOH, osmolarity 300 mOsm/L.
Standard whole-cell recording methods were used as described previ-
ously (Mayford et al., 1996). Green fluorescent protein (GFP)-positive
cells with pyramidal morphology were selected and applied for record-
ing. Briefly, patch electrodes were pulled from borosilicate 1.5 mm cap-
illary glass (Warner Instruments) on a Brown-Flaming P-97 puller
(Sutter Instruments) to a final resistance of 2–4M. The electrodes were
filled with a solution that consisted of the following (in mM): 120
KMeSO4, 11 EGTA, 10 HEPES, 0.5 CaCl2, 2Na2-ATP, 0.2 Na3-GTP, and
12 phosphocreatine, pH 7.35 with KOH, and osmolarity 270–275
mOsm. The capillaries were first filled through the tip and then backfilled
with the recording solution. Recording was performed in voltage-clamp
mode with an EPC-10 double amplifier from HEKA Elektronik, and
filtered at 5 kHz and digitized at 1 kHz. Liquid junction potentials were
not corrected but are estimated to be4 mV.
Control and drug-containing solutions were applied by gravity at a
rate of 1.5 ml/s using a rapid three-barrel capillary superfusion device
(Warner Instruments) with the pipette tips placed about 200 m from
the recorded cell. Each capillary had a tip diameter of 500 m, and the
distance from center to center was 700 m. The pipette assembly was
attached to a motor, allowing fast lateral motions controlled by the ac-
quisition software PatchMaster 2.32 (HEKA Elektronik). Dose–response
curves were obtained as follows: after recording a stable current,
pyramidal-like neuronswere exposed for 4 s to increasing concentrations
of NMDA (1 to 3000 M) in the presence of a saturating (200 M)
concentration of glycine, a glycine receptor antagonist (picrotoxin, 1
M), and 15 M CNQX to block non-NMDA glutamate receptors, and
peak current amplitude was measured. To avoid current inactivation,
drugs were applied every 60 s. Glycine, glutamate, NMDA, and picro-
toxinwere purchased fromSigma.Dose–response curveswere fittedwith
a Hill equation as follows: I  Imax/[1  (EC50/C)
n], where I, Imax, C,
EC50, and n are the agonist-activated current, maximal agonist-activated
current, agonist concentration, the concentration for 50% of the re-
sponse, and the Hill coefficient, respectively. NMDA current desensiti-
zationwasmeasured onNMDAcurrents evoked by coapplication (4 s) of
500 M NMDA and 200 M glycine at 60 mV holding potential. The
current decay was fitted with a single exponential using an analysis soft-
ware (FitMaster 2.35; HEKA Elektronik), and tau values were calculated
to present the current desensitization rate.
EPSPs in medium spiny neurons
Brains (P18–P28), after removal from the skull, were submerged in ice-
cold (1°C) artificial CSF (ACSF) containing the following (inmM): 125
sucrose, 53NaCl, 2.5KCl, 1MgCl2, 1.25NaH2PO4, 2CaCl2, 26NaHCO3,
and 25 dextrose, osmolarity 310–315mOsm, and 1 kynurenic acid, bub-
bled with 95% O2/5% CO2. Coronal slices (300 m) cut with a VT1200
microtome (Leica) were moved to 35°C ACSF for 50 min, after which
they were allowed to cool to room temperature in a regular ACSF for up
to 8 h. All experiments were performed at room temperature (20°C).
Patch pipettes were pulled with a final 4–6 M resistance from 1.5 mm
glass (World Precision Instruments) on a P-1000 Puller (Sutter Instru-
ments) using 1.5 mm glass (WPI) and filled with the following (in mM):
130 KMeSO4, 7 KCl, 10 HEPES, 0.05 EGTA, 2MgATP, 1 NaGTP, and 12
Na-phosphocreatine, adjusted with KOH to pH 7.3–7.4. Bipolar stimu-
lating electrodes (FHC) were placed in close (1 mm) proximity of the
anterior commissure of the nucleus accumbens region. For each neuron,
stimulation strength was adjusted until synaptic responses were of the
desired amplitude (10–20mV). Acquisition of EPSPs started only after
recording satisfactorily stable EPSPs. We performed all recordings in
whole-cell current clamp in infrared–differential interference contrast
mode using a Scientifica microscope equipped with Olympus optics,
including a two-station objective nose (10 and 60). Neurons were
visualized with a CCD video camera (Orca-03; Hamamatsu) connected
to a focusing tower (50mmmotorized travel in both axis) equipped with
a cube controller. Whole-cell current-clamp recordings were performed
using an EPC-10 double amplifier (HEKA) controlled by PatchMaster
2.43, an acquisition software (HEKA), running on an Apple MacPro.
Current and voltage traces were acquired at a 20 kHz sampling rate and
filtered at 2 kHz. Series resistance (20–35 M) and capacitance were
compensated for and EPSPs amplitude was measured with FitMaster
2.43 (HEKA).
Striatal Setdb1-small interfering RNA injections
A set of three mouse Setdb1 Stealth small interfering RNA (siRNA),
SETDB1MSS234817, SETDB1MSS234815, and SETDB1MSS294563
(Invitrogen), were tested in NIH mouse 3T3 cells. The most robust
decrease (up to 70%) in Setdb1 expression at the mRNA level was de-
tected 60 h after transfection of cells exposed to the Setdb1-siRNA
SETDB1MSS294563 (D03 CCAACCUGUUUGUCCAGAAUGUGUU;
D04 AACACAUUCUGGACAAACAGGUUGG), which was used for the
following in vivo knockdown experiments. To deliver the Setdb1-siRNA
into ventral striatum, P16–P20 CK-Setdb1 animals were anesthetized
with a ketamine (100 mg/kg)/xylazine (10 mg/kg) mixture administered
intraperitoneally, and thereafter placed on a stereotactic frame (Stoelting)
equippedwith amouse adapter. Bilateral injection coordinates according
to the mouse brain atlas (Franklin and Paxinos, 2001) were (from
bregma)1 mm anteroposterior (AP),	1 mmmediolateral (ML), and
3.5 mm dorsoventral (DV). A 10 l Hamilton syringe was used for
injection. The syringe was vertically attached to a probe holder con-
nected to a micropump (Stoelting) and filled with Setdb1-siRNA
(SETDB1MSS294563) or vehicle control solution and inserted 3.5 mm
deep into the mouse brain. Setdb1-siRNA (2 g/l) dissolved in 5%
sterile glucose, mixed with six equivalent of linear 22 kDa polyethyleni-
mine (ExGen 500; #RO521; Fermentas) as transfection reagent, was de-
livered into each side over a duration of 5 min. After each injection, the
syringe was left in place for another 4 min to prevent backflow. Sixty
hours after surgery, brain tissue adjacent to injection needle tracks was
sliced for medium spiny neuron EPSPs recordings, anti-myc immuno-
histochemistry, and anti-Setdb1 immunoblotting as described above.
Hippocampal NR2B/Grin2b siRNA delivery
TodeliverNR2B/Grin2b siRNA into the hippocampus of adult C57BL6/J
mice, 22 gauge guidance cannulae (Plastics One) weremounted onto the
skull with dental cement and closed with 28 gauge dummy cannulae to
prevent tissue ingrowth. Coordinates were (from bregma) 1 mm AP,
	1mmML, and 2.0mmDV.After surgery,micewere allowed to recover
for 7 d. For siRNA injection, the dummy cannulae was replaced by the
actual internal cannulae (28 gauge), whichwas attached via a 50-cm-long
polyethylene tube to a Hamilton (10l) syringe fitted into amicropump
(Soelting). Two microliters of siRNA mixture, comprising of equimolar
ratios for three siRNAs (GRIN2BMSS204919, GRIN2BMSS204917,
GRIN2BMSS204918; Invitrogen), or 2 l of vehicle as a control was
delivered bilaterally, over a duration of 2 min for each side. To avoid
stress, during siRNA delivery, mice were unrestrained and freely moving
in their home cage. After each injection, the internal cannulae was left in
place for another 4 min to prevent backflow before the guidance cannu-
lae was closed again with the guidance cannulae. The siRNAmixture was
injected once daily for 3 d. Tail suspension was performed 24 h after the
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last injection, and then hippocampal tissue cubes (2  2  2 mm)
surrounding the cannula track were harvested for anti-NR2B
immunoblotting.
Behavioral assays
For each of the behavioral tests, CK-Setdb1/0 mice were housed in the
same cage as theirwild-type littermates (except for the sucrose preference
test). Only adult male mice were used. All tests were scored blindly.
Sucrose preference test. Hedonia/anhedonia was determined by a su-
crose preference test in animals not deprived of food or water as de-
scribed previously (Aonurm-Helm et al., 2008). Two days before the test,
micewere single housed in regularMakrolonmouse cages (20 30.5 cm,
16.5 cmhigh). The test was performed over 10 d, duringwhichmicewere
given the choice to drink either tap water or a 1% sucrose solution (su-
crose dissolved in tap water). To avoid loss of fluid, the solutions were
administered in bottles equipped with a no-leak, double-ball-point
drinkingmechanism. Every 24 h, all bottles were weighed to estimate the
amount of liquid consumed by themice. Solutions were freshly prepared
every second day. Sucrose consumption was calculated as a percentage of
the amount of total liquid consumed. Data were analyzedwith a two-way
ANOVA, with genotype (wild-type vs transgenic) as the between groups
factor and day as the within groups factor, followed by Newman–Keuls
post hoc test.
Tail suspension test. Animals were suspended with a paper clip
wrapped with tape around the tail, 0.75 cm from the tip, and then hung
from a mounted hook 50 cm above the tabletop. Animals showing tail
climbing behaviors were removed from this test. The whole test was
videotaped, and the time spent immobile during a 6 min testing period
was then scored by a trained observer.
Forced swim test. Animals were placed into a 4 L Pyrex beaker (13 cm
diameter, 24 cm height) filled with 22°C water, 17 cm deep. The time
spent immobile during a 6min testing periodwasmeasured. Immobility,
evaluated by a blind observer, was defined according to the criteria as
described previously (Schramm et al., 2001).
Learned helplessness. A learned helplessness paradigm was conducted
as described previously (Caldarone et al., 2004). Learnedhelplessnesswas
induced in mice by administering 120 inescapable foot shocks (IESs) for
4 s each at 0.3 mA once every 26 s over a 1 h session in a closed compart-
ment (Gemini Avoidance System; San Diego Instruments). In total, two
sessions of IESs spaced24 h apart were given. Twenty-four hours and
7 d after the second session, animals were tested in a shuttle escape task to
determine their learned helplessness behavior. Animals were given 30
escape trials with 30 s intervals between each trial. The initial five trials
featured a 0.3 mA shock with an open door to an adjacent “safe” com-
partment for escape. Shock stimulus was terminated at escape or after
26 s, whichever was shorter. The remaining trials proceeded similarly;
however, the escape route (door opening) was presented 2 s after shock
onset. Shock stimulus was terminated at escape or after 24 s, whichever
was shorter. The latency to each escape was recorded, and the averaged
latency from 30 trials was used to measure both learned helplessness as
well as the subsequent recovery from helplessness.
Shock reactivity. Animals were placed into an inescapable testing
chamber and subjected to subsequent foot shocks with 2 s duration at
0.05, 0.1, 0.3, 0.5, and 0.7 mA with 28 s intervals. Animal behaviors
induced by foot shockweremonitored and scored as follows: flinching, 1;
vocalizing, 2; running, 3; jumping, 4. Shock reactivity was presented as
the total score reached after each trial of shock.
Passive avoidance. The test apparatus consisted of two chambers di-
vided by an automatic guillotine door: one chamber was illuminated by
an overhead light and the other kept in dim light. On habituation day,
animals were first introduced into the lighted chamber with the connect-
ing door closed. After 2 s, the door was opened and the animals were
allowed to freely explore for 5 min. On the training day (24 h after
habituation day, preshock), the animals were introduced into the lighted
chamber with the connecting door open. The latency to enter the dim
chamber was recorded. Once the animal entered into the dim chamber,
the door was closed, and an inescapable foot shock (2 s duration, 0.5mA)
was delivered in the dim chamber. Animals were left in the dim chamber
for 10 additional seconds after shock and then returned to their home
cages. Twenty-four hours or 7 d after training (after shock), animals were
introduced into the light chamber with the connecting door open, and
the latency to enter the dim chamber was recorded. A maximum testing
time of 5 min was given.
Contextual and tone-induced fear conditioning. A fear conditioning
protocol was used as described previously (Reijmers et al., 2006), with
minormodifications. On day 1, animals were subjected to a training trial
by placing them in a chamber (Gemini Avoidance System; San Diego
Instruments) with context A: methanol scented, grid floor, cue light on.
After 3 min of habituation, four tone–shock pairings were presented 1
min apart. Each pairing consisted of a 20 s tone simultaneously ending
with a 2 s, 0.5mA inescapable foot shock. Animals remained in context A
for 1 min after the last tone–shock pairing. On day 2, the day 1 training
trial was repeated with the first 3 min used to measure context freezing
(24 h after first context A exposure). On day 3, animals were tested for
tone freezing (24 h after last tone–shock pairing) in a chamber with
context B: ethanol scented, cue light off, left chamber wall covered with
orange craft foam and back chamber wall with white/blue-striped con-
tact paper. After a 3 min baseline, the tone was presented for 20 s, during
which time freezing was measured. On day 7, animals were placed in
context A for 3 min to measure context freezing (7 d after first context A
exposure); on day 8, animals were placed in context B to measure tone
freezing (7 d after last tone–shock pairing). In sham control groups,
animals received tone but no shock stimulus in day 1 and day 2 trials.
Behavior was video recorded and the total duration of freezing (bouts of

1 s of immobility) was scored during the indicated time interval.
Novelty-induced locomotion (ambulatory beam breaks). Locomotion
was monitored in a rectangular test chamber (19.1  29.2  12.7 cm)
with clean bedding, using a photocell-beam-based computer detecting
system (San Diego Instruments). Mice were placed into the test chamber
for 90 min under standard room lighting conditions. The beam
breaks were counted every 5 min to evaluate the spontaneous loco-
motor activity.
Rotarod. Rotarod (Ugo Basile; 47600) was used to measure motor
coordination in mice. The rotarod was set up with a slow acceleration
mode, in which the rotation speed is accelerated from 2 to 40 rpm in 5
min. Mice were subjected to 10 consecutive 5 min trials with a 5 min
intertrial interval. Twenty-four hours later, mice were tested by receiving
three consecutive trials (at 5 min intervals), and the mean latency to fall
off or, alternatively, to make a passive rotation was used to present the
performance.
Light/dark box. The box (15 15 23 cm) consisted of one brightly
lit, open chamber connected by a small hole (4.5 cm) to a darkened,
enclosed second chamber. Animals were introduced into the lit compart-
ment, and the time spent in each compartment was manually recorded
for 5 min after the first transition, with a 10 min maximum time.
Elevated plusmaze. The elevated plusmaze (MedAssociates) consisted
of two open arms and two closed arms situated opposite each other and
separated by a 6 cm square center platform. Each runway was 6 cmwide by
35 cm long. In addition, the open arms had lips 0.5 cm high to prevent the
mice from slipping from the arm, and the closed arms were surrounded on
three sides by 20 cm walls. The floors and walls were made from black
polypropylene. For each test, the animalwas introduced in the center square
and thenallowed toexplore freely for5min.The time spentonopenarms, in
closed arms, or in the center square was recorded separately.
Results
Setdb1 occupancy in neuronal chromatin is limited to a small
subset of genes
Setdb1 mRNA expression is widespread throughout the murine
CNS, including a large majority of neurons (Lein et al., 2007). In
adult mouse cerebral cortex, immunoreactivity for full-length,
180 kDa Setdb1 is readily detectable (Fig. 1A). To explore the
genomic targets of Setdb1 in neurons, we generated transgenic
CK-Setdb1 mice expressing a functional, myc-tagged full-length
Setdb1 cDNA under control of the CaMKII  (CK) promoter
(Fig. 1B). Two transgenic lines, from different founders, showed
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the expected, neuron-specific expression pattern, with nuclear
localization, in cortical layers II–VI, hippocampus, striatum, and
other telencephalic (and diencephalic) structures (Fig. 1C,D).
The CK-Setdb1mice showed a several-fold increase in Setdb1
mRNA levels in multiple areas of the forebrain, compared to
wild-type littermates (fold change in CK-Setdb1, mean 	 SEM:
cortex, 2.7 	 0.1; striatum, 1.9 	 0.4; hippocampus, 5.7 	 1.4,
n 4–5/group; p 0.05–0.01;Mann–Whitney test). Expression
of themyc-tagged transgenic proteinwas associatedwith a robust
increase in full-length, 180 kDa Setdb1 immunoreactivity, as
determined with two different anti-Setdb1 antibodies (Fig. 1E).
This reflected an approximately twofold increase in Setdb1 pro-
tein, when normalized to GAPDH “housekeeping” protein
(mean 	 SEM: CK-Setdb1, 0.49 	 0.01; wild-type, 0.19 	 0.14,
n  3/group; p  0.05; Mann–Whitney test). To test whether
increased Setdb1 protein results in upregulated HMT activity,
including H3K9 methylation, chromatin extracts from anti-
H3K9me3 immunoprecipitates were probed—without previous
PCR amplification—with amajor satellite sequence to label peri-
centric repeats. These are defined by A/T rich major satellite re-
peats composed of105 copies of a 234 bp unit (Waterston et al.,
2002) and high levels ofH3K9methylation (Martens et al., 2005),
which in part is regulated by Setdb1 (Lee et al., 2008; Loyola et al.,
2009; Fritsch et al., 2010). Indeed, pericentric H3K9me3 in CK-
Setdb1 forebrain was increased by 
50% from wild-type (Fig.
1F) (chip to input, mean	 SEM: CK-Setdb1, 0.41	 0.10; wild-
type, 0.26 	 0.06; n  12/group; p  0.05; Wilcoxon signed
rank), thereby suggesting that H3K9HMT activity is upregulated
in pericentric heterochromatin in the transgenic animals. This
H3K9 hypermethylation of the major satellite repeats in CK-
Setdb1 forebrain was specific, because H3K9me3 immunoreac-
tivity in tissue extracts, which include the entire fraction of
chromatin-bound and free histones, were not significantly dif-
ferent between transgenic and wild-type hippocampus, or pre-
frontal cortex or striatum (supplemental Fig. S1, available at
www.jneurosci.org as supplemental material). The observation
that totalH3K9methylation is not increased inCK-Setdb1 forebrain
is not too surprising, however, given that the murine genome con-
tains at least six or seven H3K9-specific methyltransferase enzymes
(Kouzarides, 2007), many of which are expressed in adult mouse
brain (Lein et al., 2007).
The pull-down of cross-linked chromatin with an anti-myc
antibody confirmed the presence of 180 kDa mycSetdb1 immu-
noreactivity in CK-Setdb1 forebrain, but not in wild-type mice
(Fig. 1G). Thus, the approach to immunoprecipitate myc-tagged
chromatin proteins, although originally described in yeast (Ren
et al., 2000), is also suitable for mouse brain. We then profiled
genomic occupancies of neuronal Setdb1 in adult forebrain by
chromatin immunoprecipitation using anti-myc antibody in
conjunction with an Affymetrix (genomic DNA) tiling array
(chip-chip) covering murine chromosomes 6, 8, and 16 exclud-
ing repeats. The initial rationale in choosing this particular chro-
mosomal array was to include mouse chromosome 16 sequences
syntenic to a portion of human 22q11.2 conferring high risk for
affective disorder and psychosis as a microdeletion (DiGeorge/
Velo-cardio-facial/22qDS) syndrome (Mukai et al., 2008). Sig-
nificant peaks, calculated by MATscores with a 600 bp sliding
window, were limited to altogether 70 sites across chromosomes
6, 8, and 16, but no Setdb1 signal was observed within the 22qDS
homolog (supplemental Table S2, available at www.jneurosci.org
as supplemental material). Instead, among these 70 sites were at
least 29 annotated gene hits from a total of4000 genes of chro-
mosomes 6, 8, and 16 represented on the array. These included 13
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of 29 sites located approximately 30 kb or
less from the nearest TSS (Table 1). This
finding is consistent with the notion that
Setdb1 is involved in transcriptional reg-
ulation (Schultz et al., 2002; Seum et al.,
2007). Strikingly, among the 29 genes tar-
geted by Setdb1 (out of4000 genes rep-
resented on the array) were (i)Grin2a and
Grin2b, the sole twoNMDA receptor sub-
units on the array, and (ii) Grid2, encod-
ing the glutamate delta-2 receptor (Table
1). Because three of the altogether four
ionotropic glutamate receptor genes rep-
resented on different portions of chromo-
somes 6, 8, and 16 (Grid2, Grik1, Grin2a,
Grin2b) were targeted by Setdb1, there
was a highly significant, 
200-fold en-
richment for multiple Gene Ontology
(GO) categories involving glutamate re-
ceptors and excitatory neurotransmission,
including GO:0060079 (regulation of exci-
tatory postsynaptic membrane potential)
and GO:051899 (membrane depolariza-
tion). We conclude that chromatin sur-
rounding glutamate receptor genes is
targeted by Setdb1, which otherwise is
bound to1%of annotated genes in nuclei
of mature neurons. In addition, Setdb1 lo-
cated to several distinct sequences within a
gene cluster on chromosome 6 encoding
natural killer cell immunoglobulin-like re-
ceptors (Table 1, supplemental Table S2,
available at www.jneurosci.org as supple-
mental material).
Setdb1 regulates the expression of
NMDA receptor subunit Grin2b
Next, we tested whether the Setdb1-
mediated increased H3K9 HMT activity
in transgenic forebrain (Fig. 1G) would
result in repressive chromatin remodeling and downregulated
expression of NMDA receptor subunits that are targeted by
Setdb1 (Table 1). To this end, we measured in adult CK-Setdb1
mice and their wild-type littermates the mRNA levels of the con-
stitutive subunit Grin1 (NR1) and the two Setdb1 target genes,
Grin2a and Grin2b, with the latter gene being of particular inter-
est given that Setdb1 is positioned only 30 kb from its TSS (Table
1). Notably, adult CK-Setdb1mice, compared to wild-type litter-
mates, showed a highly significant, 20–50% reduction in Grin2b
mRNA and protein levels in hippocampus, and a similar ten-
dency in prefrontal cortex (Fig. 2A,B). In contrast, levels of
Grin2a (which, unlikeGrin2b, is targeted by Setdb1 at the 3 end,

270 kb downstream of the TSS) (Table 1) were not significantly
altered (Fig. 2A,B). Likewise, expression of the constitutive sub-
unit, Grin1 (NR1), remained unaltered in CK-Setdb1 animals
(Fig. 2A). The lower level of Grin2b in CK-Setdb1 brain could be
attributable to transcriptional repression, because H3K9
methylation at Grin2b’s Setdb1 target site was significantly in-
creased in the transgenic animals (CK-Setdb1, 1.20 	 0.18; wild-
type, 0.78	 0.07; n 11/group; p 0.05; Mann–Whitney test).
To test whether Setdb1 elicits an inhibitory effect on Grin2b
transcription in other species, including human, we transfected
U87MG glioma cells, which express low to moderate levels of
GRIN2B and other glutamate receptor genes (Stepulak et al.,
2009), with mycSetdb1 cDNA. Indeed, three of three mycSetdb1
transfected cultures, compared to controls, showed a more than
twofold increase (mean	 SEM, 2.3	 0.1) in Setdb1 occupancy at
proximal intronic GRIN2B sequences, which are homolog to the
Setdb1 target site within themurineGrin2b (Fig. 3A–C). This was
associated with a significant, 20% reduction in GRIN2B ex-
pression, compared to controls with histoneH3 as a loading con-
trol (mean 	 SEM: Setdb1 transfected cultures, 0.78 	 0.04;
control cultures, 1.00 	 0.02; n  3/group; p  0.05; Mann–
Whitney test) (Fig. 3D). Together, these findings suggest that
expression of GRIN2B is sensitive to changes in SETDB1 levels
and activity.
Chromatin architectures at theGrin2b locus
The studies above demonstrate that transgenic Setdb1 preferen-
tially targets, both in human and mouse, GRIN2B/Grin2b in-
tronic sequences that are30 kb distal from the TSS. To rule out
that this genomic occupancy is an off-target effect of the trans-
gene, we checked Setdb1 occupancies at Grin2b in forebrain of
wild-type mice with anti-Setdb1 ChIP. Remarkably, highest lev-
els of Setdb1 were measured at the same sequence (in intron III)
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that had emerged as the primary target of transgenic Setdb1 (Fig.
4A), essentially ruling out that this is an off-target. Furthermore,
a second, smaller wild-type Setdb1 ChIP signal was detected at
the gene’s TSS (Fig. 4A). This distinct binding profile of Setdb1
was highly specific, when compared to the genomic occupan-
cies of the KAP-1 transcriptional corepressor (also known as
TRIM28/TIF1b/KRIP1), which is a putative binding partner
of Setdb1 in repressive chromatin remodeling complexes
(Ayyanathan et al., 2003). KAP-1, in striking contrast to Setdb1,
showed peak levels within the first 2–3 kb from Grin2b’s TSS
followed by a broad but weak distribution spread at least 60 kb
into theGrin2b gene (Fig. 4A). Of note, the KAP-1 peakmatched
the location of the sole CpG island found at the 5 end ofGrin2b.
Furthermore, when the genome-wide distribution of H3K4me3,
an epigenetic mark that is sharply regulated around TSSs and
associated with positive or negative regulation of gene expression
(Shilatifard, 2008), wasmapped in wild-type forebrain, the signal
at the Grin2b locus was almost exclusively confined to the first
few kilobases downstream of its TSS (Fig. 4A). Therefore, the
distribution pattern both of the KAP-1 repressor and of the
H3K4me3 mark, and the position of Grin2b’s sole CpG island at
its 5 end, together highlight the potential importance of the first
2–3 kbs following this gene’s TSS for transcriptional regulation.
However, the studies above also demonstrate that Setdb1 is
primarily found at Grin2b intronic sequences that are removed
(30 kb) from the gene’s TSS. To understand how this binding
pattern could be associated with Setdb1’s negative regulation of
Grin2b expression (Figs. 2, 3), we used chromosome conforma-
tion capture technology (Dekker, 2008) to map physical interac-
tions within 40 kb of Grin2b TSS. We prepared 3C libraries from
DNA ligase-treated HindIII digests of formalin-cross-linked nu-
clei isolated from adultmouse forebrain (wild-type), as described
in Materials and Methods. Then, 3C interaction maps were gen-
erated with specific HindIII fragment as anchors (Fig. 4Ba–Bc).
In 3C maps, the interaction frequency between chromatin frag-
ments is measured as the relative intensity of the corresponding
PCR products, compared to Grin2b BAC reference templates,
which are thought to represent all possible fragment interactions
in equal amounts (Dekker, 2006;Miele et al., 2006) (seeMaterials
and Methods).
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Ms tatctatCTTCCTTTACCTGCCATTTCAAAGAA CTGACTTTCCTTTTCACTGCTGTACGGCACTCAGATCTGTCACTGA 
Hu ------tCTTTCTTCA-----CACCCCCAACCAAAAAAAAACCCAATAAAAATCTTTAATAATTTTCTCTCTTACTGCTATAT-ATACACAGATCCACTTTTGA 
                     **** *** *     **   * **  **** * ******   ** * ****  * * ****  * * ****** **    ** ******      ***
CAAG GGATGATGCTGAA ATTCCCCA
AAAGACAACCCAGCCAAGACCTTTG
Figure3. Setdb1negatively regulatesGRIN2Bexpression inhumanU87-MGglioma cells.A,B, Setdb1 target sites atGrin2b (mouse) andGRIN2B (human).A, Top, Distributionof scores calculated
withMAT software in the 1.3Mb region ofmouse chromosome 6 enclosing the Grin2b gene. Scores are calculated over a 600 bp interval and assigned to the tiling probe at the center of the interval.
Scores are plotted as a custom track in the UCSC genome browser (http://genome.ucsc.edu/). The significance threshold is 3.66 for p 1e5. Bottom, Sequence alignment between mouse (Ms)
and human (Hu) GRIN2B gene loci at Setdb1 target sites. Conserved sequences are indicatedwith asterisks.B, Schematic overview shows Setdb1 target sites in 5-untranslated regions frommouse
(solid arrow) and human (dashed arrow) Grin2b/GRIN2B loci. C, Representative blot shows mycSetdb1 immunoreactivity in human glioma (U87-MG) culture transfected with mycSetdb1 cDNA
(Set), but not control (C). Histone H3 was used as loading control. D, Representative immunoblots show Setdb1 and GRIN2B immunoreactivity in Set and control U87-MG cultures.
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In 3C experiments, the degree of interaction typically is very
high between adjacent 3C fragments, but then rapidly declines to
very low or undetectable levels when probed with fragments/
primers further removed from the anchor (Dekker, 2006, 2008).
This is also what we observed, as shown in the 3C map anchored
on theHindIII fragment positioned 5 from theGrin2b TSS (Fig.
4Bc, primer 2). This would suggest that chromatin upstream
from Grin2b’s TSS shows very little interaction with chromatin
structures other than those in its immediate proximity. In strik-
ing contrast, the 3Cmap anchored on theHindIII fragment com-
posed of the first 5 kb followingGrin2b’s TSS (Fig. 4Ba, primer 3)
revealed two peaks. There was, in addition to the expected inter-
action with neighboring primers, a second 3C peak from PCR
products with primers positioned 30 kb downstream from the
TSS (Fig. 4Ba), which included the aforementioned Setdb1 target
sequence in intron III (Fig. 4A,Ba–Bc, red line). The specificity of
the above peak was further confirmed in “reciprocal” 3C maps
now anchored on the 30 kb portion of intron III (Fig. 4Bb,
primer 10), which again showed comparatively high levels of
interaction with the HindIII fragment/primer representing the
TSS and 5 kb of Grin2b (Fig. 4, blue), whereas the interaction
with the surrounding fragments was much lower (Fig. 4Bb). No
products were obtained from PCRs of 3C libraries that were not
treated with DNA ligase (supplemental Fig. S2, available at www.
jneurosci.org as supplemental material). These findings together
suggest that there is a chromatin loop caused by a physical inter-
action between sequences 30 kb downstream fromTSS,which are
targeted by Setdb1 (Fig. 4C), and the 5 end of Grin2b, which
represents part of the promoter including the TSS and the sole
CpG island in that region aswell as high levels of a Setdb1 binding
partner, the KAP-1 repressor. These findings, which were ob-
tained from wild-type brain, further highlight the potential role
of Setdb1 for Grin2b expression.
Functional alterations of the NMDA receptor complex in
CK-Setdb1 hippocampus
The NMDA receptor subunit, NR2B/Grin2b, is assembled into
synaptic and extrasynaptic NMDA receptor complexes and is
involved in a wide range of functions including various types of
neuronal plasticity (Thomas et al., 2006). To explore whether
Setdb1, by decreasing Grin2b expression, alters NMDA receptor
function in CK-Setdb1 mice, we recorded NMDA currents
in whole-cell patch clamp on somata of acutely dissociated
hippocampal neurons from P18–P21 animals. To visualize
mycSetdb1-expressing neurons in the dish, we crossed CK-
Setdb1 mice with a transgenic line expressing GFP-conjugated
histone H2B under control of the CK promoter (Jiang et al.,
2008b). Coexpression of the two transgenes was apparent in hip-
pocampal sections (Fig. 5A) and confirmed by counting of nuclei
extracted from hippocampus (including the CA sectors), with
99.4% (723 of 727 counted) GFP-positive neuronal nuclei ex-
pressing mycSetdb1. Recordings were performed on GFP-
positive cells with pyramidal neuron-like morphology (Fig. 5B).
When NMDA currents were evoked with NMDA concentrations
ranging from 1 M to 3 mM, in the presence of 15 M CNQX to
block non-NMDA glutamate receptors, current amplitudes were
Figure 4. Chromatin architecture at the Grin2b locus in wild-type brain. A, Binding patterns
of Setdb1 methyltransferase (black dots) and, for comparison, KAP-1 (white dots) in adult
mouse forebrain (wild-type) within 60 kb from the Grin2b TSS as indicated. Data are expressed
as the chip-to-input ratio (mean	SEM);n3 chip experiments/antibody.Notice that Setdb1
occupancy is highest at the target site in intron III (marked by red line), corresponding to same
target site shown in Figure 3 and Table 1. Notice further that KAP-1 occupancy is highest within
first the 2–3 kb from the Grin2b TSS. Notice also that ChIP-seq (ChIP followed by massively
parallel sequencing) H3K4me3 markings (shown in gray) at Grin2b are almost exclusively lim-
ited to this site. This portionofGrin2b is part of itsmostproximalHindIII fragment (bluebox) and
harbors a CpG island as indicated. B, 3C profiles from adult mouse forebrain (wild-type) for
proximal 35 kb ofGrin2b; colored bars each represent a specificHindIII restriction fragment. The
position and orientation of 3C primers 1–12 is as indicated. Ba–Bc, Each 3C profile is anchored
on specific restriction fragment/primer as indicatedby coloredhorizontal bar in interactionmap. The
y-axes show thenormalized pixel intensities (fromagarose gel) for the specific PCRproduct from the
anchoringprimer andeachof the remaining11primers as indicatedby color code.Dataare shownas
themean	SEMfromtwo3C libraries processed in triplicate.Notice inBaandBb that thereare
comparatively high levels of interaction between 5 kb of the 5 end of Grin2b (blue) and
fragments 30 kb farther downstream from the TSS. The Setdb1 target site is shown as a red
line. Notice also (Bc) that this interaction is not detected with the anchoring fragment
4
immediately upstream of the TSS. C, Model for Grin2b chromatin loop, based on data shown in
A and B. The loop tethers the 5 end of the gene to intronic sequences
30 kb downstream
from the TSS, including the Setdb1-target site. Notice that whereas the majority of Setdb1 is
bound to the 3 part of the loop, a smaller fraction is found at the 5 part (see also A).
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maximum with 1 mM NMDA and rapidly declined with lower
concentrations (Fig. 5C). Dose–response curves, including the
EC50, were nearly equivalent between wild-type (324 M) and
CK-Setdb1mice (310M) (Fig. 5C). Because the EC50 for NMDA
is higher for receptors containing Grin2a/NR2A and Grin2b/
NR2B, as compared to the remaining NR2 subunits, Grin2c/
NR2C and Grin2d/NR2D (which are expressed at low levels in
P18 and older hippocampus) (Laurie and Seeburg, 1994), we
conclude that CK-Setdb1 animals do not show a generalized loss
of NMDA receptor function. However, heteromeric receptors
comprised of Grin2b subunits (together with the constitutive
subunit Grin1) show slower current decay rates compared to
Grin2a (Vicini et al., 1998; Tovar et al., 2000). Therefore, we
compared Ca2-independent desensitization kinetics in CK-
Setdb1 and wild-type neurons. NMDA currents were evoked
around 60 mV holding potential by coapplication of 500 M
NMDA with saturating concentrations of glycine (200 M), and
fast and slow current decay were best fit by a single exponential
(Fig. 5D). Indeed, the averaged  for GFP-positive neurons from
CK-Setdb1 mice (0.76 	 0.13 s; n  16) was significantly de-
creased compared to those from the control group (genotype
CK-Setdb10/0/CK-H2BeGFP/0; 1.21 	 0.22 s; n  8) (Fig. 5D).
Together, these findings suggest that Setdb1 repressesGrin2b ex-
pression in neurons, thereby affecting NMDA receptor subunit
composition and desensitization kinetics.
Medium spiny neuron EPSPs of CK-Setdb1mice are not
sensitive to NR2B antagonist
The findings above suggest that general NMDA receptor signal-
ing is preserved in CK-Setdb1 forebrain, although the partial de-
crease inNR2B/Grin2b expression could, in addition to changing
biophysical properties of the receptor (see above), render the
transgenic brain less sensitive to the effect of specific NR2B an-
tagonist drugs. To explore this, we assessed the acute effects of the
NR2B-selective antagonist drug ifenprodil on NMDA EPSPs of
striatal medium spiny neurons (MSNs) located in the nucleus
accumbens/ventral striatum, which, like the hippocampus, is
part of the neuronal circuitry regulating affective and motiva-
tional behaviors.
The current–voltage relationship and other biophysical prop-
erties that define MSNs (Martin et al., 1997) were indistinguish-
able between CK-Setdb1 and control mice (Fig. 6A). Thus, the
rectification in the hyperpolarized range of potential was clearly
visible, as was the ramp in response to depolarizing current steps.
Furthermore,MSNs action potential firing patterns in both wild-
type and CK-Setdb1mice showed little adaptation and displayed
a fast afterhyperpolarization whose amplitude similarly declined
as a function of the number of action potentials. Then, we evoked
NMDA EPSPs every 20 s for up to 10 min before (baseline) (Fig.
6C, y-axis) and during 100 M ifenprodil exposure in the pres-
ence of 10MCNQX. Representative traces fromwild-type mice
show that ifenprodil strongly inhibits NMDA-EPSP amplitudes
(Fig. 6B). When monitored 5 min after ifenprodil exposure, the
drug had reduced the NMDA-EPSP amplitudes by nearly 50% in
five of five wild-type neurons (Fig. 6B,C). In contrast, four of five
neurons from transgenic striatum were essentially insensitive to
ifenprodil’s effect under these experimental conditions (Fig.
6B,C). Only one of fiveMSNs fromCK-Setdb1micewas sensitive
to ifenprodil’s inhibitory effect on NMDA-EPSP amplitudes; the
neuron-to-neuron variability in ifenprodil sensitivities could be
attributable to differences in Setdb1 transgene expression. These
data further confirm that NMDA receptor subunit composition
and function is altered because of a downregulation of Grin2b in
CK-Setdb1 animals.
Next, we wanted to explore whether the Setdb1-mediated
downregulation of NR2B/Grin2b in striatum is reversible. We
therefore repeated the neuronal recordings in the striatal slice
preparation in CK-Setdb1 animals that were exposed to a single
injection of Setdb1-siRNA60 h before tissue harvest. Pilot studies
in 3T3 cells identified a specific siRNA that mediated a strong
downregulation of Setdb1 transcript (see Materials and Meth-
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Figure 5. Accelerated NMDA current desensitization in CK-Setdb1 hippocampal neurons.
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pyramidal neuron layer of the hippocampal CA1 field from CK-Setdb1/CK-H2BeGFP mice. Nei-
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day 18. C, Left, NMDA currents evoked by NMDA from 1M to 3 mM for different hippocampal
neurons. Horizontal bar represents timing of drug exposure. Right, Dose–response plot of peak
NMDA currents from CK-Setdb1 (CK-Setdb1/0/CK-H2BeGFP/0; filled circle) and controls (CK-
Setdb10/0/CK-H2BeGFP/0; open circle); n  8–10/genotype. Notice that dose–response
curves are indistinguishable between CK-Setdb1 and control mice.D, Left, Representative indi-
vidual currents of three hippocampal neurons in response to 500MNMDA. Red lines represent
single exponential fits of current desensitization; values (seconds) are indicated above the
traces. Right, Scatter plot shows individual NMDA current desensitization rate (open circle) and
averaged rate (blackdots) forGFP-positiveneurons fromCK-Setdb1and controlmice.Notice the
significantly faster desensitization in GFP-positive CK-Setdb1 neurons in comparison to control
neurons. n 8–19/group. *p 0.05 (one-tailedMann–Whitney test). Scale bars:A, 40m;
B, 10m. Data are mean	 SEM.
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ods), and this siRNA mediated a robust
decrease in striatal Setdb1 protein at 60 h
after injection (Fig. 6E). Indeed, the
siRNA-mediated knockdown of Setdb1 in
transgenic striatum was sufficient to re-
store the neuronal response to ifenprodil
by reducing NMDA EPSPs 50% from
baseline (Fig. 6D), which is of similar
magnitude when compared to the drug’s
reducing effects of NMDA EPSPs in wild-
type striatum (Fig. 6C). Based on this, we
conclude that Setdb1’s inhibitory effect
on Grin2b-mediated neurotransmission
is reversible.
Antidepressant-like behavioral changes
in CK-Setdb1 mice
Next, we hypothesized that NR2B/Grin2b-
regulated behaviors are altered in CK-
Setdb1mice. A partial decrease in Grin2b
expression is thought to underlie some of
the behavioral plasticity after repeated
amphetamine exposure (Mao et al., 2009),
and moreover, there is evidence that the
antidepressant-like effects of nonspecific
NMDA receptor antagonists in human
and rodent are mimicked by drugs that
selectively target the Grin2b subunit
(Maeng et al., 2008; Preskorn et al., 2008).
Importantly, in these models for (partial)
Grin2b inhibition, general cognition and
memory remained intact. In contrast,
mice with a complete genetic ablation of
Grin2b in hippocampus and other corti-
colimbic circuitry results show deficits in
synaptic plasticity and learning andmem-
ory (von Engelhardt et al., 2008). There-
fore, we predicted that Setdb1-mediated
partial repression of Grin2b could alter
the animal’s motivational and affective
states without necessarily compromis-
ing memory or general neurological
functions. Indeed, CK-Setdb1 mice ex-
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Figure 6. Ifenprodil-mediated inhibition of NMDA EPSPs in CK-Setdb1 andwild-typeMSNs. A, Current–voltage (I–V) relation-
ship of representative nucleus accumbens/ventral striatum neurons from wild-type and CK-Setdb1 mice recorded in whole-cell
patch clamp in a slice of tissue. Notice the strong rectification in the hyperpolarizing range, the large action potential overshoot,
presence of a ramp, and hyperpolarized resting potential (approximately 87 mV) that identify these neurons as MSNs. B,
Representative NMDA EPSPs from wild-type and transgenic neurons, recorded at resting membrane potential before (10 M
CNQX) and during ifenprodil perfusion (10 M CNQX 100 M ifenprodil). Notice that the NMDA-EPSP amplitude remained
unchanged inCK-Setdb1neuronafter ifenprodil exposure.C,MeanamplitudesofNMDAEPSPs evokedevery20 sbefore (CNQX) and
during ifenprodil exposure (CNQX ifenprodil) in slices from wild-type (open circles) and CK-Setdb1 mice (filled circles). EPSPs
4
were evoked in an Mg 2-free ACSF, and their amplitudes
were expressed as a percentage of baseline (CNQX). Data
(mean	 SEM) are shown for four transgenic and five wild-
type neurons (animals). A fifth CK-Setdb1 neuron was re-
moved as an outlier (Grubbs’ test; two-way ANOVA, genotype,
F(1,6) 105.2; p 0.001). *p 0.05 (Newman–Keuls post
hoc test). D, Same recording as in C but from CK-Setdb1 mice
treated with Setdb1-siRNA (filled triangles). n 4 neurons.
Notice that in C, wild-type but not CK-Setdb1 neurons show
reduced NMDA EPSPs from baseline (dotted line) in the pres-
ence of ifenprodil. Notice also that in D, siRNA treatment re-
stores NMDA-EPSP sensitivity to ifenprodil in CK-Setdb1
neurons. E, Representative examples of anti-myc immunohis-
tochemistry (left) and anti-Setdb1 immunoblots (right) from
the ventral striatum of untreated and Setdb1-siRNA-treated
CK-Setdb1mice. Scalebar, 100m.Notice the robustdecrease
of myc and Setdb1 immunoreactivity after siRNA treatment.
Data in D and E are from brains harvested 60 h after siRNA
delivery into striatum.
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hibited, compared to wild-type littermates, antidepressive phe-
notypes in behavioral paradigms for anhedonia (increased
sucrose consumption over the course of 10 d without changes in
total fluid intake in CK-Setdb1 line 1) (Fig. 7A) and despair, as
evidenced by decreased immobility in tail suspension and Porsolt
swim tests (mean 	 SEM, tail suspension: CK-Setdb1 (line 1),
134	 8 s; wild-type, 172	 16 s; forced swim:CK-Setdb1 (line 2),
145	 9 s; wild-type, 211	 12 s; n 8–11/group; p 0.05–0.01,
Mann–Whitney test). Importantly, similar behavioral changes
could be elicited in wild-type (C57BL/6J) mice treated with the
NR2B selective antagonist “R-(R,S)--(4-hydroxyphenyl)--
methyl-4-(phenylmethyl)-1-piperidine propranol (Ro25-6981; 5
mg/kg, i.p.) These include the aforementioned sucrose consump-
tion paradigm after subchronic treatment (Fig. 8A) and behav-
ioral despair when measured 30 min after acute treatment
(mean 	 SEM, tail suspension: Ro25-6981, 76 	 9.2 s; saline,
191	 9.4 s, n 10/treatment; p 0.01; Mann–Whitney test). A
similar antidepressant-like phenotype was observed in C57BL6/J
mice treated with bilateral daily injections, for 3 d, of Grin2b-
siRNA into the hippocampus, which resulted in a robust,
50% decrease in NR2B/Grin2 protein (Fig. 8B) (mean	 SEM,
tail suspension: Grin2b-siRNA, 150 	 20 s; vehicle, 188 	 11 s;
n 6–7/group; p 0.05 by Student’s t test; p 0.07 by Mann–
Whitney test). To further confirm the antidepressive phenotype
of our CK-Setdb1 animals, we applied the learned helplessness
paradigm, in which the state of ”helplessness“ was measured by
the escape latencies (in testing sessions when flight becomes pos-
sible) 1 or 7 d after 2 d of exposure to mild but inescapable
repeated foot shocks (training sessions). One day after the end of
training, both transgenic and littermate control mice showed es-
cape latencies approaching, on average, 20 s (Fig. 7B). However,
7 d after training, CK-Setdb1 but not their littermate controls
showed a significant,
50% reduction in escape latencies as com-
pared to day 1, indicating accelerated recovery from learned help-
lessness in the transgenic animals. The difference between
genotypes in escape latencies on day 7 was significant (Fig. 7B).
Of note, the decrease in despair-related immobility and in-
creased sucrose consumption in the Setdb1 transgenic mice is
comparable to similar behavioral changes observed in wild-type
mice exposed to acute or chronic treatment with conventional
antidepressants (Berton and Nestler, 2006), suggesting that up-
regulation of Setdb1 in neurons mediates an antidepressant-like
behavioral effect. This phenotype, which was observed in two
independent transgenic lines, was not associated with a more
generalized alteration in the retention of foot shock-associated
memories (as measured in passive avoidance and fear condition-
ing paradigms) (Fig. 9B,C), or a deficit in shock sensitivity or
perception (Fig. 9A). Furthermore, the maintenance of body
weight, novelty-induced locomotion activity, and anxiety-related
behaviors remained unaltered in the transgenic animals, and only a
subtle decrease (7% from controls) was observed in rotarod per-
formance (supplemental Fig. S3, available at www.jneurosci.org as
supplemental material). These findings indicate that the observed
antidepressant-like phenotype in the CK-Setdb1 mice is not ex-
plained by a generalized alteration in neurological functions.
Discussion
The present study demonstrates that increased expression and
activity of Setdb1 histonemethyltransferase in forebrain neurons
is associated with an antidepressant-like phenotype in behavioral
paradigms related to anhedonia, despair, and helplessness. These
behavioral effects occurred in the context of a limited genomic
occupancy of Setdb1 in neuronal chromatin, which was confined
to a very small set (1%) of genes and, unexpectedly, included
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the twoNMDA receptor subunits, NR2A/
Grin2a and NR2B/Grin2b. Although ex-
pression of Grin2a and overall NMDA
receptor function was preserved in
CK-Setdb1 mice, these animals were af-
fected by a partial, 20–50% decrease in
Grin2b levels, which resulted in altered
NMDA desensitization kinetics and in-
sensitivity to the effect of NR2B-selective
antagonist drugs. Therefore, these studies
provide the first evidence that a member
of the H3K9 HMT family of molecules
regulates specific motivational and affec-
tive behaviors, and the expression of a
neurotransmitter receptor system that is
of crucial importance for neuronal signal-
ing and plasticity.
Presently, the molecular mechanisms
mediating the selectivity of Setdb1 target
sites in neuronal chromatin, including the
unexpected preference for multiple iono-
tropic glutamate receptor subunits, remain
unknown. However, these observations
from mouse forebrain resonate with recent
reports in the fruit fly. Of note, theDrosophila
ortholog of the mammalian Setdb1, Egg/
dSetdb1, preferentially binds to the fourth
chromosome, a small structure com-
prised of 4.2 Mb that harbors only 80
genes, including the fly’s sole metabo-
tropic glutamate receptor gene (Seum et
al., 2007; Tzeng et al., 2007; Riddle et al.,
2009). This affinity of Egg/dSetdb1 could
be explained by the high density of repeats
on the fly’s fourth chromosome, which is
five times higher than on the other auto-
somes (Riddle et al., 2009). The affinity of
Setdb1 for repeat sequences was also ap-
parent in the present study, as evidenced
by increased H3K9 methylation in peri-
centric heterochromatin of transgenic an-
imals (Fig. 1F), and it is noteworthy that
some of the Setdb1-binding sites onmouse
chromosomes 6, 8, and 16, including the
Grin2b target, are positioned within large
introns and flanked by repeat sequences
(Fig. 3A). It is unlikely, however, that repeat
density is the sole determinant governing
Setdb1’s unusual occupancy pattern inneu-
ronal chromatin, and a mechanistic under-
standing of this apparently highly regulated
process awaits further investigations. Based
on our 3C and Setdb1-ChIP experiments at
the Grin2b locus, Setdb1 is found in an in-
tronic chromatin segment involved in a loop formation via interac-
tionwith theGrin2bpromoter (Fig. 4).Whetherornot thesehigher-
order chromatin structures at Grin2b are representative for other
Setdb1 target sites in the genome remains to be clarified. It is likely
that chromatin loopingsatGrin2bandmanyothergenomic lociplay
a critical role for neuronal function. Although the findings reported
here represent some of the first studies on three-dimensional chro-
matin architecture for a glutamate receptor gene, the overall impor-
tance of higher order chromatin is best illustrated by the fact that
simple nucleosome/core histone templates compact DNA about
sevenfold, which is more than two orders of magnitude below the
level of genome compaction observed in a vertebrate cell nucleus
(Ho and Crabtree, 2010).
One attractive model (Fig. 4C) would be that, via the loop,
Setdb1-enriched chromatin associates with the Grin2b promoter
through an interaction with its binding partner, the KAP-1 (or
TRIM28/TIF1b/KRIP1) transcriptional corepressor (Ayyanathan et
al., 2003). Interestingly, mice with forebrain-specific ablation of
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KAP-1 exhibit elevated levels of anxiety and stress-related im-
pairments in memory tasks (Jakobsson et al., 2008). Therefore,
the broadly opposing patterns of behavioral changes after KAP-1
loss of function (Jakobsson et al., 2008) and Setdb1 gain of func-
tion (present study), which were not associated with generalized
neurological defects in these different mouse models, further
highlight the importance of theKAP-1-Setdb1 repressor complex
for the regulation of affective behaviors.
Among the Setdb1-regulated genes likely to mediate the
mood-related effect of this HMT, the NMDA receptor subunit
NR2B/Grin2b could play a prominent role. First,GRIN2B carries
strong genetic risk for bipolar disorder in the Ashkenazi (Fallin et
al., 2005; Avramopoulos et al., 2007). Second, in the present
study, behavioral changes in wild-type mice treated with an
NR2B antagonist, or with siRNA-mediated NR2B knockdown in
hippocampus, were similar to those observed in (drug-naive)
transgenic Setdb1 animals. The findings presented here are also
in good agreement with the recent reports on antidepressant-like
effects of NR2B antagonists in rodent and human (Maeng et al.,
2008; Preskorn et al., 2008). Although these and other NMDA-
related drug studies (Berman et al., 2000; Zarate et al., 2006;
Salvadore et al., 2009) are extremely promising, the side-effect
profile of NMDA receptor antagonists, including confusion and
impaired cognition and memory, prohibits wider clinical appli-
cations. Based on the findings presented here, upregulation of
Setdb1 methyltransferase activity may provide an alternative an-
tidepressant strategy, because Setdb1-mediated partial down-
regulation of NR2B/Grin2b expression is much less likely to be
detrimental for neuronal functions compared to NMDA antago-
nist drug treatment (Darrah et al., 2008) or the complete genetic
ablation of the Grin2b gene, which results in significant memory
deficits (von Engelhardt et al., 2008). Our finding that Grin2b
expression in human glioma cells decreased after upregulation of
Setdb1 occupancy within this gene, in conjunction with a previ-
ous study reporting that histone methylation levels at NMDA
receptor and many other glutamate receptor genes are subject to
developmental and region-specific regulation in the humanbrain
(Stadler et al., 2005), further speaks to the therapeutic poten-
tial of Setdb1 and other HMT-mediated chromatin remodel-
ing mechanisms.
The mechanism(s) through which NR2B/Grin2b downregu-
lation results in antidepressant action are still unclear. It has been
proposed that enhancing non-NMDA, specifically AMPA, rela-
tive to NMDA ionotropic glutamate receptor signaling could un-
derly the therapeutic benefits of NMDA antagonists (Maeng et
al., 2008). In the CK-Setdb1 mice of the present study, overall
NMDA receptor density and signaling was maintained at normal
levels (Fig. 5C). Instead, a shift in NMDA receptor subunit com-
position caused by a selective decrease in NR2B/Grin2b expres-
sion (Fig. 5D) could explain the change in depression related
behaviors. In support of this hypothesis, alterations in NR2A/
NR2B ratios strongly affect synaptic plasticity and circuitry for-
mation in the developing cerebral cortex (Philpot et al., 2007;
Zhao and Constantine-Paton, 2007; Cho et al., 2009).
Furthermore, it is very likely that the Setdb1-mediated
antidepressant-like phenotype reported here involves additional
genes that are not directly related to the NMDA receptor system.
For example,Gpm6a is (likeGrin2b andGrin2a) among the list of
29 Setdb1 gene targets on chromosomes 6, 8, and 16 (Table 1).
Gpm6a encodes a glycoprotein on neuronal membranes, and ge-
netic polymorphisms within GPM6A confer a significant risk for
depression in subjects with psychosis (Boks et al., 2008). A more
comprehensive assessment of Setdb1 target genes will require
chromatin profiling across all murine chromosomes.
It is remarkable that upregulation of histone acetylation and
of H3K9 methylation, two types of histone modifications en-
riched in different portions of the genome that either define open
(acetylation) or, in case of the trimethylatedH3K9, repressed and
silenced chromatin (Berger, 2007; Wang et al., 2008; Roth and
Sweatt, 2009), both result in antidepressant-like phenotypes. Of
note,
40% of affected individuals show an incomplete response
to conventional antidepressants (Berton and Nestler, 2006), and
therefore drugs acting as specific Setdb1 activators and other epi-
genetic regulators of gene expression, including class I/II histone
deacetylase inhibitors (Tsankova et al., 2006; Duman and Newton,
2007; Schroeder et al., 2007; Covington et al., 2009;Grayson et al.,
2009; Gundersen and Blendy, 2009; Hobara et al., 2009) could
potentially benefit a substantial portion of these hitherto treatment-
resistant cases. Of note, chronic restraint stress (a preclinical
model for depression) induces the downregulation of the
H3K9me3mark in the dentate gyrus of the hippocampus, and this
can be reversed by treatment with a prototype antidepressant and
serotonin reuptake inhibitor, fluoxetine (Hunter et al., 2009). Fi-
nally, it will be interesting to explore whether interference with the
orderly regulation of other types of histonemodifications, including
arginine methylation, serine phosporylation, and lysine ubiquitiny-
lation and SUMOylation (Berger, 2007; Roth and Sweatt, 2009),
induces changes in the brain’s affective andmotivational states. It is
very likely that the rich cache of epigenetic regulators expressed in
thebrainwill include chromatin-modifyingproteins that couldpro-
vide promising targets for novel antidepressant treatment strategies.
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